Nakai Yuka, Tokuyama Emi, Yoshida Miyako, Uchida Takahiro
School of Pharmaceutical Science, Mukogawa Women's University, Nishinomiya, Japan.
Yakugaku Zasshi. 2010 Jan;130(1):95-102. doi: 10.1248/yakushi.130.95.
The purpose of this study was to evaluate the incompatibility of ceftriaxone sodium with calcium-containing products using the ionic product of precipitation, and the measurement of insoluble microparticles using a light obscuration particle counter. Appropriate volumes of 2% (w/v) calcium chloride solution were added to 0.4-2 mg/ml ceftriaxone isotonic sodium chloride solution, to make solutions with a final calcium ion concentration of 1.25 mmol/l. The solutions were gently agitated and stored at 37 degrees C for 24 h. The number of insoluble microparticles with a diameter less than 10 microm in the mixed sample solution, determined using a light obscuration particle counter, was increased when the ceftriaxone concentration was > or =0.8 mg/ml. The Saturation Index (defined as the ratio of the ionic product to the solubility product constant) of the prepared mixed solution was 1.1. A white precipitate could be observed visually when the ceftriaxone concentration of the sample solution was 7 mg/ml; the Saturation Index of the solution was 9.7. The effect of the calcium source on incompatibility with ceftriaxone sodium was also evaluated. The numbers of insoluble microparticles in sample solutions made by adding calcium chloride to the sample were significantly higher than those made by adding calcium gluconate. These results suggest that ceftriaxone should not be co-administered with calcium-containing products even if no precipitation is observed visually. There will still be insoluble microparticles caused by incompatibility in the sample solution when the Saturation Index of the solution is over 1.0.
本研究的目的是利用沉淀离子积评估头孢曲松钠与含钙产品的不相容性,并使用光阻法颗粒计数器测量不溶性微粒。将适量体积的2%(w/v)氯化钙溶液加入到0.4 - 2mg/ml的头孢曲松等渗氯化钠溶液中,制成最终钙离子浓度为1.25mmol/l的溶液。将溶液轻轻搅拌并在37℃下储存24小时。当头孢曲松浓度≥0.8mg/ml时,用光阻法颗粒计数器测定的混合样品溶液中直径小于10微米的不溶性微粒数量增加。所制备混合溶液的饱和指数(定义为离子积与溶度积常数之比)为1.1。当样品溶液中头孢曲松浓度为7mg/ml时,肉眼可观察到白色沉淀;该溶液的饱和指数为9.7。还评估了钙源对与头孢曲松钠不相容性的影响。向样品中添加氯化钙制成的样品溶液中的不溶性微粒数量明显高于添加葡萄糖酸钙制成的样品溶液。这些结果表明,即使肉眼未观察到沉淀,头孢曲松也不应与含钙产品同时给药。当溶液的饱和指数超过1.0时,样品溶液中仍会因不相容性产生不溶性微粒。